UP!

News

Adamas Pharmaceuticals, Inc. -1.63% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-02-27 Future report Set alerts
Q2 2020 2020-08-06 -0.37 0.00
Q1 2020 2020-05-07 -0.59 -0.59
Q4 2019 2020-02-25 -0.83 -0.83
Q3 2019 2019-11-07 -0.99 -0.99
Q2 2019 2019-08-08 -0.90 -0.90
Q1 2019 2019-05-09 -1.08 -1.08
Q4 2018 2019-03-04 -1.06 -1.06
Q3 2018 2018-11-01 -1.22 -1.22
Q2 2018 2018-08-02 -1.26 -1.26

Ratings

2016-06-28 Reiterated Rating Noble Financial Buy $25.00
2016-06-23 Reiterated Rating Mizuho Buy
2016-06-22 Reiterated Rating Credit Suisse Buy
2016-06-22 Reiterated Rating Credit Suisse Group AG Buy
2016-06-17 Initiated Coverage Noble Financial Buy $25.00
2016-06-16 Upgrade Mizuho Neutral to Buy $22.00
2016-06-15 Reiterated Rating JMP Securities Buy
2016-06-14 Reiterated Rating Piper Jaffray Overweight $44.00
2016-06-14 Reiterated Rating Piper Jaffray Cos. Overweight $44.00
2016-06-13 Reiterated Rating Mizuho Hold
2016-05-12 Lower Price Target Mizuho Neutral $17.00 to $16.00
2016-05-12 Reiterated Rating Cowen and Company Buy
2016-04-28 Boost Price Target Mizuho Neutral $14.00 to $17.00
2016-04-01 Initiated Coverage JMP Securities Outperform $29.00
2016-02-25 Reiterated Rating Mizuho Neutral $26.00 to $14.00
2016-01-26 Reiterated Rating Aegis Buy
2016-01-19 Initiated Coverage Cowen and Company Outperform $45.00
2016-01-19 Initiated Coverage Mizuho Neutral $26.00
2016-01-12 Reiterated Rating Piper Jaffray Overweight $37.00 to $44.00
2015-12-31 Reiterated Rating Credit Suisse Buy
2015-12-30 Reiterated Rating Aegis Buy
2015-12-29 Reiterated Rating Needham & Company LLC Buy
2015-12-25 Reiterated Rating Credit Suisse Buy
2015-12-24 Boost Price Target Credit Suisse Outperform $35.00 to $37.00
2015-12-24 Boost Price Target Needham & Company LLC $38.00
2015-12-24 Reiterated Rating Aegis Buy $29.00
2015-12-23 Reiterated Rating Needham & Company LLC Buy $33.00 to $38.00
2015-09-22 Initiated Coverage Aegis Buy $29.00
2015-09-11 Reiterated Rating William Blair Outperform $35.00
2014-11-07 Reiterated Rating Credit Suisse Outperform $30.00 to $27.00
2014-08-12 Boost Price Target Credit Suisse $26.00 to $30.00
2014-05-05 Initiated Coverage William Blair Outperform $35.00
2014-05-05 Initiated Needham Buy $33
2014-05-05 Initiated Coverage Needham & Company LLC Buy $33.00
2014-05-05 Initiated Coverage Credit Suisse Outperform $26.00
2014-05-05 Initiated Coverage Piper Jaffray Overweight $32.00
2016-06-28 Reiterated Rating Noble Financial Buy $25.00
2016-06-23 Reiterated Rating Mizuho Buy
2016-06-22 Reiterated Rating Credit Suisse Buy
2016-06-22 Reiterated Rating Credit Suisse Group AG Buy
2016-06-17 Initiated Coverage Noble Financial Buy $25.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
GREAT POINT PARTNERS LLC 13.23%  (2216351) ADMS / INFU /
aeris Capital Equity Investments, L.P. 9.92%  (1662128) ADMS /
MDV IX LP 1.72%  (287992) ADMS /
Ericson William W. 1.72%  (287992) ADMS / FUEL / PACB /
Went Gregory T Chief Executive Officer 1.09%  (182610) ADMS /
KING RICHARD Chief Operating Officer 0.30%  (50661) ACRX / ADMS /
LIEBERBURG IVAN M 0.29%  (48000) ADMS /
BOOTH RICHARD H 0.27%  (45778) ADMS / NU / THG /
Rhodes Jennifer J General Counsel 0.20%  (34128) ADMS / MDVN /
MERRIWEATHER ALFRED G Chief Financial Officer 0.16%  (27125) ADMS /
MDV VII LP 0.15%  (25661) ADMS / PFPT /
Patni Rajiv Chief Medical Officer 0.13%  (21515) ADMS / OCRX /
Prentiss Christopher B Chief Accounting Officer 0.11%  (17758) ADMS /
DAWSON WILLIAM J Chief Financial Officer 0.09%  (14284) ADMS / MGRC /
McClure Natalie SVP, Product Development 0.05%  (8340) ADMS /
MAHONEY DAVID L 0.02%  (2628) ADMS / CORT / SYMC /
DAG Ventures Management III, LLC 0.01%  (1474) ADMS / YUME /

Comments